US Bancorp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.53M Buy
4,700
+110
+2% +$35.9K ﹤0.01% 958
2025
Q1
$1.24M Sell
4,590
-192
-4% -$51.8K ﹤0.01% 1029
2024
Q4
$1.13M Sell
4,782
-796
-14% -$187K ﹤0.01% 1075
2024
Q3
$1.53M Sell
5,578
-1,516
-21% -$417K ﹤0.01% 952
2024
Q2
$1.72M Buy
7,094
+534
+8% +$130K ﹤0.01% 895
2024
Q1
$980K Sell
6,560
-691
-10% -$103K ﹤0.01% 1128
2023
Q4
$1.39M Sell
7,251
-17
-0.2% -$3.25K ﹤0.01% 973
2023
Q3
$1.29M Sell
7,268
-149
-2% -$26.4K ﹤0.01% 956
2023
Q2
$1.41M Sell
7,417
-588
-7% -$112K ﹤0.01% 921
2023
Q1
$1.6M Sell
8,005
-26
-0.3% -$5.21K ﹤0.01% 885
2022
Q4
$1.91M Sell
8,031
-212
-3% -$50.4K ﹤0.01% 830
2022
Q3
$1.65M Buy
8,243
+197
+2% +$39.4K ﹤0.01% 848
2022
Q2
$1.17M Sell
8,046
-2,232
-22% -$326K ﹤0.01% 1029
2022
Q1
$1.68M Buy
10,278
+679
+7% +$111K ﹤0.01% 957
2021
Q4
$1.63M Buy
9,599
+1,008
+12% +$171K ﹤0.01% 992
2021
Q3
$1.62M Buy
8,591
+108
+1% +$20.4K ﹤0.01% 957
2021
Q2
$1.44M Buy
8,483
+239
+3% +$40.5K ﹤0.01% 1022
2021
Q1
$1.16M Buy
8,244
+6,186
+301% +$873K ﹤0.01% 1069
2020
Q4
$268K Buy
2,058
+824
+67% +$107K ﹤0.01% 1744
2020
Q3
$179K Buy
1,234
+119
+11% +$17.3K ﹤0.01% 1816
2020
Q2
$165K Buy
1,115
+71
+7% +$10.5K ﹤0.01% 1852
2020
Q1
$114K Sell
1,044
-120
-10% -$13.1K ﹤0.01% 1922
2019
Q4
$133K Buy
1,164
+48
+4% +$5.49K ﹤0.01% 2020
2019
Q3
$89K Buy
1,116
+488
+78% +$38.9K ﹤0.01% 2217
2019
Q2
$46K Buy
628
+259
+70% +$19K ﹤0.01% 2559
2019
Q1
$35K Buy
369
+147
+66% +$13.9K ﹤0.01% 2642
2018
Q4
$16K Sell
222
-76
-26% -$5.48K ﹤0.01% 2889
2018
Q3
$26K Buy
298
+142
+91% +$12.4K ﹤0.01% 2831
2018
Q2
$15K Sell
156
-213
-58% -$20.5K ﹤0.01% 3014
2018
Q1
$45K Buy
369
+128
+53% +$15.6K ﹤0.01% 2663
2017
Q4
$30K Sell
241
-222
-48% -$27.6K ﹤0.01% 2792
2017
Q3
$55K Buy
463
+393
+561% +$46.7K ﹤0.01% 2521
2017
Q2
$6K Hold
70
﹤0.01% 3156
2017
Q1
$4K Sell
70
-39
-36% -$2.23K ﹤0.01% 3237
2016
Q4
$4K Sell
109
-478
-81% -$17.5K ﹤0.01% 3220
2016
Q3
$40K Sell
587
-37
-6% -$2.52K ﹤0.01% 2554
2016
Q2
$34K Buy
624
+44
+8% +$2.4K ﹤0.01% 2586
2016
Q1
$36K Buy
580
+467
+413% +$29K ﹤0.01% 2528
2015
Q4
$10K Buy
113
+59
+109% +$5.22K ﹤0.01% 3046
2015
Q3
$4K Sell
54
-129
-70% -$9.56K ﹤0.01% 3283
2015
Q2
$22K Buy
183
+146
+395% +$17.6K ﹤0.01% 2896
2015
Q1
$4K Sell
37
-253
-87% -$27.4K ﹤0.01% 3316
2014
Q4
$28K Sell
290
-738
-72% -$71.3K ﹤0.01% 2765
2014
Q3
$80K Sell
1,028
-2,208
-68% -$172K ﹤0.01% 2237
2014
Q2
$204K Sell
3,236
-728
-18% -$45.9K ﹤0.01% 1793
2014
Q1
$266K Sell
3,964
-147
-4% -$9.86K ﹤0.01% 1623
2013
Q4
$264K Sell
4,111
-549
-12% -$35.3K ﹤0.01% 1594
2013
Q3
$298K Buy
4,660
+2,660
+133% +$170K ﹤0.01% 1493
2013
Q2
$62K Buy
+2,000
New +$62K ﹤0.01% 2232